Derek Brown

Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents

Andrew Nesbitt, Gianluca Fossati, Marianne Bergin et al. · Inflammatory Bowel Diseases · 2007 · 473 citations

Veterinary Medicine, Immunology, Pharmacology +17

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

Anthony Shock, Linda C. Burkly, Ian Wakefield et al. · Arthritis Research & Therapy · 2015 · 107 citations · Full text

Life Sciences, Hematology, Immunology +13

Expression of Bruton's tyrosine kinase protein within the B cell lineage

Helen C. Genevier, Steve Hinshelwood, Hubert B. Gaspar et al. · European Journal of Immunology · 1994 · 106 citations

Life Sciences, Genetics, Immunology +14

Endothelial Cell E- and P-Selectin Up-Regulation in Murine Contact Sensitivity Is Prolonged by Distinct Mechanisms Occurring in Sequence

Olivier Harari, Julie McHale, Diane Marshall et al. · The Journal of Immunology · 1999 · 58 citations · Full text

Life Sciences, Cell Biology, Immunology +17

A new generation of high-affinity humanized PEGylated Fab´ fragment anti-tumor necrosis factor-α monoclonal antibodies

Neil Weir, Dee Athwal, Derek Brown et al. · Therapy · 2006 · 37 citations

Pharmacy, Medicinal Chemistry, Pharmaceutical Biotechnology +17